Dosing begins in phase I study in China of IBI-323 for advanced malignant tumors July 12, 2021 No Comments
Results of phase I trial of CRAd-S-pk7 oncolytic adenovirus delivered by neural stem cells in glioma July 12, 2021 No Comments
Evaxion presents phase I/IIa data for its cancer immunotherapy candidates, EVX-01 and EVX-02 July 9, 2021 No Comments
EpimAb Biotherapeutics commences dosing in phase I/II trials of EMB-06 and EMB-02 July 7, 2021 No Comments
FDA clears initiation of phase II trials of YH-001 and YH-003 in advanced cancers July 7, 2021 No Comments
NextCure's NC-762 enters phase I/II trial in advanced or metastatic solid tumors July 7, 2021 No Comments
RSS